会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明授权
    • Preparation of 2-amino-3-cyano-5-dialkoxymethylpyrazines and
intermediates for this method
    • 2-氨基-3-氰基-5-二烷氧基甲基吡嗪的制备及其制备方法
    • US4725689A
    • 1988-02-16
    • US776462
    • 1985-09-16
    • Hartmut LeiningerWolfgang LittmannJoachim Paust
    • Hartmut LeiningerWolfgang LittmannJoachim Paust
    • C07D241/20C07D241/26C07D403/04C07D475/04
    • C07D403/04C07D241/20C07D241/26Y02P20/55
    • 2-Amino-3-cyano-5-dialkoxymethylpyrazine derivatives of the general formula III ##STR1## where R.sup.1 and R.sup.2 are each hydrogen or a protective group usually employed for amino groups and R.sup.5 and R.sup.6 are each alkyl of 1 to 4 carbon atoms, or together form an ethylene or propylene radical which is unsubstituted or substituted by methyl, are prepared starting from a novel 3-halomethyl-5-dihalomethyl-2-aminopyrazine derivative of the formula IV ##STR2## where X is Cl or Br, via a novel intermediate of the general formula I ##STR3## where R.sup.3 is --CH.sub.2 --O--CO--CH.sub.3 (a), --CH.sub.2 OH (b), ##STR4## or --C.tbd.N (d) and R.sup.4 is --CHCl.sub.2 or --CHBr.sub.2 or, where R.sup.1 and R.sup.2 are each a protective group, R.sup.4 may furthermore be ##STR5##The compounds according to the invention are useful intermediates for the preparation of folic acid and active compounds derived from this.
    • 通式III(III)的2-氨基-3-氰基-5-二烷氧基甲基吡嗪衍生物其中R 1和R 2各自为氢或通常用于氨基的保护基,R 5和R 6各自为1-4的烷基 碳原子,或一起形成未被取代或被甲基取代的乙烯或丙烯基团,由式IV(IV)的新型3-卤代甲基-5-二卤代甲基-2-氨基吡嗪衍生物制备,其中X为 Cl或Br通过通式I的新型中间体(I),其中R 3是-CH 2 -O-CO-CH 3(a),-CH 2 OH(b),(c)或-C 3 N(d)和R4是-CHCl 2或-CHBr 2,或者其中R 1和R 2各自是保护基,R 4还可以是本发明的化合物是用于制备叶酸和活性化合物的有用中间体 由此。
    • 83. 发明授权
    • Preparation of sugar ketals
    • 糖缩酮的制备
    • US4681936A
    • 1987-07-21
    • US826317
    • 1986-02-05
    • Klaus-Peter PfaffJoachim PaustHorst Hartmann
    • Klaus-Peter PfaffJoachim PaustHorst Hartmann
    • C07H1/00B01J31/00C07B61/00C07H9/04
    • C07H9/04
    • Sugar ketals are prepared by reacting a sugar with a ketone in the presence of an acid catalyst by a process in whichA. a molecular boron trifluoride compound or trifluoromethanesulfonic acid is used in an amount of only from 0.01 to 10% by weight, based on the sugar used,B. up to a 30-fold molar excess of the ketone is used andC. the water formed during the reaction is removed continuously from the reaction mixture.In a particularly advantageous embodiment of the process, the boron trifluoride is used in the form of boron trifluoride etherate and, when the reaction is complete, this compound or the trifluoromethanesulfonic acid is rendered ineffective under non-aqueous conditions, after which the ketone is evaporated off and the reaction mixture is then subjected to fractional distillation. The process is particularly important for the reaction of L-sorbose with acetone to obtain 2,3:4,6-di-O-isopropylidene-L-sorbofuranose, which is required for the synthesis of ascorbic acid.
    • 糖缩成物是通过在酸催化剂存在下使糖与酮反应的方法制备的,其中A为分子三氟化硼化合物或三氟甲磺酸的用量,其量仅为0.01至10重量%,基于 使用的糖,B.使用高达30倍摩尔过量的酮,并且C.从反应混合物中连续除去反应期间形成的水。 在该方法的特别有利的实施方案中,三氟化硼以三氟化硼醚合物的形式使用,当反应完成时,该化合物或三氟甲磺酸在非水性条件下变得无效,之后酮蒸发 然后将反应混合物进行分馏。 该方法对于L-山梨糖与丙酮的反应特别重要,得到合成抗坏血酸所需的2,3:4,6-二-O-异亚丙基-L-山梨糖。
    • 85. 发明授权
    • Novel optically active chroman derivatives, their preparation and novel
intermediates
    • 新型光学活性苯并二氢吡喃衍生物,其制备和新型中间体
    • US4645845A
    • 1987-02-24
    • US588365
    • 1984-03-12
    • Henning-Peter GehrkenHansgeorg ErnstJoachim Paust
    • Henning-Peter GehrkenHansgeorg ErnstJoachim Paust
    • C07D311/58C07D311/72
    • C07D311/72
    • Novel optically active chroman derivatives of the general formulae Ia and Ib ##STR1## where R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are each hydrogen or alkyl and X is --OH, --O--CO-alkyl, --O-alkyl, --O-tosyl, --O-mesyl, --O-benzenesulfonyl, Cl, Br or I, are prepared by a process in which(a) the racemate of the formula I' ##STR2## is esterified in the side chain with a carboxylic acid and then acylated with an optically active carboxylic acid halide of the general formula III ##STR3## or with the corresponding carboxylic anhydride, to give a chroman derivative IV ##STR4## or (b) the racemate I' is esterified in the side chain with the carboxylic acid from which III is derived, and, if required, the resulting ester is acylated with a carboxylic acid halide to give IV' ##STR5## the resulting mixture IV or IV', which consists of two diastereomers, is resolved by fractional crystallization, the diastereomers are hydrolyzed to the alcohols Ia and Ib and, if desired, these are converted to the other compounds Ia and Ib in a conventional manner.Useful optically active chroman derivatives Ia and Ib and diastereomeric chromanyl esters IV and IV' are also claimed.
    • (Ia)其中R 1,R 2,R 3和R 4各自为氢或烷基且X为-OH,-O-CO-烷基,(C 1 -C 6)烷氧基, -O-烷基,-O-甲苯磺酰基,-O-甲磺酰基,-O-苯磺酰基,Cl,Br或I是通过以下方法制备的,其中(a)式I'(I')的外消旋物 在侧链中用羧酸酯化,然后用通式III(III)的光学活性羧酸卤化物或相应的羧酸酐进行酰化,得到苯并二氢吡喃衍生物IV(IV) 或(b)外消旋物I'在侧链中与衍生自其的羧酸酯化,如果需要,将所得酯用羧酸卤化物酰化,得到IV'(IV') 由两个非对映异构体组成的所得混合物IV或IV'通过分级结晶来拆分,非对映异构体被水解成醇Ia和Ib,如果需要,它们是转化的 以常规方式与其它化合物Ia和Ib反应。 还要求有用的光学活性色氨酸衍生物Ia和Ib以及非对映异构的色满基酯IV和IV'。
    • 86. 发明授权
    • Preparation of N-(D)-ribityl-2-phenylazo-4,5-dimethylaniline
    • N-(D) - 基] -2-苯基偶氮-4,5-二甲基苯胺的制备
    • US4360669A
    • 1982-11-23
    • US286601
    • 1981-07-24
    • Wolfram SchmidtJoachim PaustAxel Nurrenbach
    • Wolfram SchmidtJoachim PaustAxel Nurrenbach
    • C07C67/00C07C215/10C07C241/00C07C245/08C07D475/14C07H1/00C07H1/06
    • C07D475/14
    • A process for the preparation of N-(D)-ribityl-2-phenylazo-4,5-dimethylaniline (I), wherein1. in the case of pure or virtually pure (D)-ribose (III)(a) the latter is reacted with 3,4-dimethylnitrobenzene (IVa) or 3,4-dimethylaniline (IVb) and with hydrogen in the presence of a hydrogenation catalyst,(b) the resulting solution is reacted, in a conventional manner, with an acid phenyldiazonium salt solution (VI) and(c) the resulting product is isolated by crystallization, in a conventional manner, or2. in the case of crude ribose, ie. industrial mixtures of (D)-ribose and other sugars(a) the crude ribose is reacted with about equimolar amounts, based on III, of 3,4-dimethylaniline (IVb) and boric acid,(b) the boric acid ester of the Schiff base obtained from III and IVb is allowed to crystallize out and is separated off,(c) this ester is hydrogenated with hydrogen in the presence of a hydrogenation catalyst,(d) the solution is freed from catalyst and reacted, in a conventional manner, with an acid phenyldiazonium salt solution and(e) the resulting product I is isolated by crystallization in a conventional manner.
    • 制备N-(D) - 基] -2-苯基偶氮基-4,5-二甲基苯胺(I)的方法,其中1.在纯的或几乎纯的(D) - 核糖(III)(a)的情况下, 后者与3,4-二甲基硝基苯(IVa)或3,4-二甲基苯胺(IVb)和氢气在氢化催化剂存在下反应,(b)所得溶液以常规方式与酸性苯基重氮 盐溶液(VI)和(c)通过以常规方式结晶分离得到的产物,或在粗核糖的情况下, (D) - 核糖和其他糖(a)的工业混合物(a)粗核糖基于III,3,4-二甲基苯胺(IVb)和硼酸,以(b)硼酸酯的大约等摩尔量反应 允许从III和IVb获得的席夫碱结晶出并分离出来,(c)在氢化催化剂存在下,用氢气氢化该酯,(d)将溶液除去催化剂并以常规方式反应 用酸性苯基重氮盐溶液和(e)所得到的产物I通过常规方式结晶分离。